Literature DB >> 8672424

Partitioning of HIV-1 Gag and Gag-related proteins to membranes.

L S Ehrlich1, S Fong, S Scarlata, G Zybarth, C Carter.   

Abstract

The binding of HIV-1 Gag and Gag-related proteins to model membranes was examined using three experimental systems: (i) large unilamellar phospholipid vesicles (LUVs) and recombinant Gag purified from Escherichia coli; (ii) LUVs added to a mammalian cell extract in which Gag proteins were expressed by a coupled transcription/translation system; and (iii) inside-out plasma membrane vesicles purified from human red blood cells (RBC) and recombinant, purified Gag from E. coli. Several novel aspects of HIV-1 Gag membrane interactions were observed: (i) Gag proteins bound with high affinity to both model membranes with a negatively charged surface and to RBC membranes. (ii) Binding of the Gag precursor and mature Gag proteins exhibited different sensitivities to ionic strength indicating that the precursor directed membrane binding through interactions that were qualitatively and quantitatively distinct from those of any of its individual domains. Studies using energy transfer between tryptophan residues in the proteins and anthroyloxy-containing probes inserted in the LUVs indicated that the orientation of the precursor and of the mature proteins on the membrane surface were distinct; (iii) Gag oligomers appear to have facilitated high-affinity binding under high salt conditions, suggesting that protein-protein interactions led to formation of stronger electrostatic or new hydrophobic membrane binding determinants. Since binding studies with model membranes permit quantitative analysis, these experimental approaches may permit identification of interactions that drive Gag assembly on the membrane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8672424     DOI: 10.1021/bi952337x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein.

Authors:  L Dietrich; L S Ehrlich; T J LaGrassa; D Ebbets-Reed; C Carter
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Electrostatic interactions and binding orientation of HIV-1 matrix studied by neutron reflectivity.

Authors:  Hirsh Nanda; Siddhartha A K Datta; Frank Heinrich; Mathias Lösche; Alan Rein; Susan Krueger; Joseph E Curtis
Journal:  Biophys J       Date:  2010-10-20       Impact factor: 4.033

3.  Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.

Authors:  Marilia Barros; Frank Heinrich; Siddhartha A K Datta; Alan Rein; Ioannis Karageorgos; Hirsh Nanda; Mathias Lösche
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 4.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

5.  Specificity of plasma membrane targeting by the rous sarcoma virus gag protein.

Authors:  Lisa Z Scheifele; Jonathan D Rhoads; Leslie J Parent
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Binding of the C-terminal domain of the HIV-1 capsid protein to lipid membranes: a biophysical characterization.

Authors:  Francisco N Barrera; Estefanía Hurtado-Gómez; María C Lidón-Moya; José L Neira
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

7.  Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids.

Authors:  Ayna Alfadhli; Amelia Still; Eric Barklis
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

8.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

9.  In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.

Authors:  S Campbell; A Rein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.